收藏切换
Analysis on the current situation of clinical trials of inhaled preparations in China based on registration data
收藏切换
PDF
Zhen-wei XIE1, Fei TANG2, Miao WANG3, Yu-fei FENG1, Zhao-long CAO4
Chinese Journal of Clinical Pharmacology | 2026, 42(10) : 1479 - 1484
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2026, 42(10): 1479-1484
Regulatory Science Column
Analysis on the current situation of clinical trials of inhaled preparations in China based on registration data
Full
Zhen-wei XIE1, Fei TANG2, Miao WANG3, Yu-fei FENG1, Zhao-long CAO4
Affiliations
  • 1.Clinical Trial Institution, Peking University People’s Hospital, Beijing 100044, China
  • 2.Department of Respiratory and Critical Care Medicine, Peking University People’s Hospital, Beijing 100044, China
  • 3.Beijing Haijinge Pharmaceutical Technology Co., Ltd., Beijing 100161, China
  • 4.Department of General Practice, Peking University People’s Hospital, Beijing 100044, China
Published: 2026-05-28 doi: 10.13699/j.cnki.1001-6821.2026.10.021
Outline
收藏切换
Objective

To analyze the current status and development trends of registered clinical trials of inhalation preparations in China, and to provide references for drug development and clinical evaluation.

Methods

Clinical trials of inhalation preparations registered on the NMPA Platform for Drug Clinical Trial Registration and Information Publicity from its inception to December 31, 2025 were retrieved. Descriptive statistical analysis was conducted on the basic information, design types, drug characteristics, and indications of the trials.

Results

A total of 445 registered clinical trials of inhalation preparations were included, which had entered a rapid development phase in the past five years. The trials were predominantly domestic (94.61%) and bioequivalence (BE) studies (48.31%). The most common dosage forms were liquid inhalation formulations (44.04%) and dry powder inhalations (35.51%). Research and development were highly concentrated on asthma and chronic obstructive pulmonary disease, with inhaled corticosteroids and their combinations being the main directions. In contrast, trials involving childer and adolescents accounted for only 4.94%, and explorations in areas such as pulmonary fibrosis and pulmonary infections remained relatively limited. Sponsors and research resources were primarily concentrated in the more developed pharmaceutical regions such as Beijing, Shanghai, and Jiangsu.

Conclusion

The development of inhalation preparations in China has entered a phase of rapid growth, characterized by a dominance of generic drugs, a high concentration of therapeutic areas, and differentiated development of dosage forms. Future efforts should focus on unmet clinical needs and innovative research and development of high-technical-barrier dosage forms to promote high-quality development in this field.

inhalation preparations  /  clinical trials  /  asthma  /  chronic obstructive pulmonary disease
Zhen-wei XIE, Fei TANG, Miao WANG, Yu-fei FENG, Zhao-long CAO. Analysis on the current situation of clinical trials of inhaled preparations in China based on registration data[J]. Chinese Journal of Clinical Pharmacology, 2026 , 42 (10) : 1479 -1484 . DOI: 10.13699/j.cnki.1001-6821.2026.10.021
Year 2026 volume 42 Issue 10
PDF
158
26
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2026.10.021
  • Receive Date:2026-04-11
  • Online Date:2026-08-06
  • Published:2026-05-28
Article Data
Affiliations
History
  • Received:2026-04-11
Funding
Affiliations
    1.Clinical Trial Institution, Peking University People’s Hospital, Beijing 100044, China
    2.Department of Respiratory and Critical Care Medicine, Peking University People’s Hospital, Beijing 100044, China
    3.Beijing Haijinge Pharmaceutical Technology Co., Ltd., Beijing 100161, China
    4.Department of General Practice, Peking University People’s Hospital, Beijing 100044, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2026.10.021
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT